Lantern Pharma Launches Webinar Wednesdays Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development

Webinar Wednesdays is planned to be held on the last Wednesday of each month - starting on Wednesday, April 24th with the first webinar on the increasing prevalence of non-small cell lung cancer in...

Related Keywords

United States ,Riyadh ,Ar Riya ,Saudi Arabia ,Kishor Bhatia ,Tesaro Glaxosmithkline ,Igor Astsaturov ,Paulf Engstrom ,Reggie Ewesuedo ,Care At Fox Chase Cancer Center ,Department Of Hematology Oncology ,Ohio State University ,Securities Exchange ,Children Cancer Center Riyadh ,Malignancy Program ,Linkedin ,Astrazeneca ,Lantern Pharma Inc ,Department Of Hematology ,Pfizer ,Marvin Concetta Greenburg Pancreatic Cancer Institute ,Exchange Commission On ,Clinical Development At Lantern Pharma ,National Cancer Institute ,Nasdaq ,Lantern Pharma ,Webinar Wednesdays ,Wednesday April ,Starlight Therapeutics ,Non Small Cell Lung ,Joseph Treat ,Vice Chair ,Medical Director ,Ambulatory Care ,Fox Chase Cancer ,Vice President ,Clinical Development ,Pancreatic Cancer ,Associate Professor ,Concetta Greenburg Pancreatic Cancer Institute ,Inaugural Holder ,Chief Scientific Officer ,Cancer Center Riyadh ,Securities Act ,Securities Exchange Act ,Risk Factors ,Annual Report ,Exchange Commission ,Pharma Disclosure Channels ,Disseminate Information ,